Pharmaceutical

Pills

Propylene Glycol USP/EP (PG USP/EP) is tested against the specifications of the United States, European and Japanese Pharmacopoeia, plus the Food Chemicals Codex (FCC) and complies with requirements for pharmaceutical applications worldwide. PG USP/EP from Dow also meets the requirements of the Brazilian Pharmacopoeia.

It is used in pharmaceutical products as an excipient (non-active ingredient or starting material) or solvent in oral, topical and injectable drug products.

PG USP/EP from Dow is approved worldwide for use as a non-active ingredient in pharmaceutical drug formulations. PG USP/EP from Dow is tested against and complies with the specific requirements of the current United States Pharmacopeia (USP), and the European (EP) and Japanese (JP) Pharmacopoeias.

PG USP/EP from Dow also meets the requirements and standards of the U.S. Food and Drug Administration (U.S. FDA), Food Chemicals Codex (FCC) and Brazilian Pharmacopoeia (FB).

Dow’s product also complies with the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use.

We recommend consultation of the appropriate regulations or with a qualified advisor for guidance on specific applications.

For Additional Information

International Pharmaceutical Excipients Council†
IPEC-Americas Inc†
U.S. Pharmacopeia†

Find a Distributor, or Contact Us for specific product and application support.



† Note: These links allow you to leave dow.com. We are not responsible for content on external sites. Please see our privacy policy for more information.